CTRI/2021/04/032863已完成未知
Clinical validation study to evaluate the efficacy and safety of unani pharmacopoeical formulation-Qurs-e-Dawa-ul-Shifa in Zightuddam Qawi(Hypertension) - HT
CCRUM0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Following are inclusion criteria:
- •1 Subjects of either sex in the age group of 18-65 years.
- •2 Subjects of primary hypertension
- •3 Subjects of Grade- 1 Hypertension with Systolic BP [130–139]/ Diastolic BP [80–89]
- •4 Presence of any of the following symptoms and signs:
- •1 Suda(Headache)
- •2 Duwar(Vertigo)
- •3 Khafaqan(Palpitation)
- •4 Kasal (Laziness)
- •5 Takan(Fatigue)
- •Waj-us-sadr(Chest pain)
- •Kasrat-e-baul(Polyurea)
- •NabzMumtali (Pulsusplenus)
排除标准
- •Patients will be excluded who have any or more of the following conditions:
- •1.Pregnant and lactating women
- •2.Chronicity of disease more than 10 years
- •3.Subjects with SBP =140 mmHg and Diastolic BP >90 mmHg
- •4.Subjects with Secondary Hypertension
- •5.Subjects taking any other medication affecting blood pressure like NSAIDs and OCPs in females
- •6.Obese subjects – BMI >30
- •7.Systemic diseases requiring long term-treatment, e.g., DM-II, Malignancy, Epilepsy, cardiac and kidney diseases.
- •8.Subjects with Sinus Bradycardia, i.e., pulse rate less than 60/min
研究者
相似试验
招募中
3 期
A confirmatory clinical study of ISN001 in patients with epidermolysis bullosaJPRN-jRCT2033210128Ishiko Akira8
招募中
3 期
Diferent doses of lactase in subjects with intolerance lactoseRBR-53hjzkutracom Indústria e Comércio Ltda.
进行中（未招募）
不适用
Testing a food supplement in improving strength, power and mental alertnessHealthy volunteerISRCTN86507492Farmaceutici Procemsa S.p.A.60
已完成
不适用
Clinical study to evaluate the efficacy, pharmacokinetics and safety of immunoglobulin intravenous (human) 10% (NewGam) in patients with primary immunodeficiency diseasesCommon variable immunodeficiencyPrimary immunodeficiency diseases (PID)Haematological DisordersISRCTN05425999Octapharma AG (Switzerland)50
已完成
2 期
A Clinical study on cervical spondylosis using thengaai thuruval ottradam (external therapy)CTRI/2021/02/031542Government Siddha medical college and hospital40